Overall Revenue Growth
Third quarter 2025 global sales from continuing operations totaled $2.8 billion, increasing 5% on a reported basis and 2% on an operational basis.
Advanced Surgery Segment Performance
Sales in Advanced Surgery totaled $306 million and grew 11% globally, reflecting strong demand and commercial execution.
Healthcare Systems & Technologies Segment
Sales in the quarter totaled $773 million, increasing 2%, driven by 4% growth in the U.S. for Care and Connectivity Solutions.
Adjusted Earnings Growth
Adjusted earnings from continuing operations were $0.69 per share for the quarter, increasing 41% versus the prior year.